IMPlications of IMP2 in RNA Biology and Disease. Review uri icon

Overview

abstract

  • Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) is an RNA-binding protein that positively regulates m6A-modified RNAs involved in critical cellular processes such as metabolism, oncogenesis, and immune function. Here, we elucidate facets of IMP2 biology, including several mechanisms of action on RNA, factors that regulate IMP2 expression, its relevant biological target RNAs, its role in normal development and disease, and its potential as a therapeutic target. IMP2 is a multi-level regulator of metabolism, influencing pathways linked to diabetes, obesity, and adipose function. Through genomic amplification and transcriptional overexpression in cancer cells, IMP2 can drive the initiation and progression of multiple cancer types, and high expression is associated with decreased overall survival of patients with cancer. IMP2 influences normal immune function, inflammation, macrophage polarization, and tumor immune evasion. IMP2 has emerged as a promising therapeutic target, particularly for cancers and metabolic diseases.

publication date

  • March 7, 2025

Research

keywords

  • Neoplasms
  • RNA
  • RNA-Binding Proteins

Identity

PubMed Central ID

  • PMC11942581

Scopus Document Identifier

  • 105001093969

Digital Object Identifier (DOI)

  • 10.3390/ijms26062415

PubMed ID

  • 40141058

Additional Document Info

volume

  • 26

issue

  • 6